BioCentury | Jan 15, 2021
Product Development

Delfi and Earli series A rounds show there’s room for new entrants in early cancer detection

...OrbiMed, the series A round had participation from existing investors including Menlo Ventures, Samsara Biocapital, Illumina Ventures...
...company raised a $5.5 million seed financing led by Menlo Ventures and including Samsara BioCapital, Illumina Ventures...
BioCentury | Oct 17, 2020
Finance

Menlo to continue healthcare push at intersection of tech, life sciences with $500M fund

...as CEO of digital health and next-generation protein analysis companies as well as an entrepreneur-in-residence at Illumina Ventures...
BioCentury | Jul 23, 2020
Product Development

Encoded to drive first gene therapy into clinic with GV-led $135M series D

...the vector. The financing drew participation from existing investors Matrix Capital Management, Arch Venture Partners, Illumina Ventures...
BioCentury | May 18, 2020
Finance

$65M round positions SQZ Biotech for potential IPO, 2021 catalysts

...investor Temasek, bringing its total of private capital raised to $167 million. Existing investors GV, Illumina Ventures...
BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...series A led by Boehringer Ingelheim Venture Fund (BIVF) and Panacea Venture, with participation from Illumina Ventures...
BioCentury | Mar 25, 2020
Finance

‘Diversified’ gut-brain axis company Kallyope heading to clinic with $112M series C

...the new round: The Column Group, Lux Capital, Polaris Partners, Euclidean Capital, Two Sigma Ventures, Illumina Ventures...
BioCentury | Sep 30, 2019
Company News

Vertex seeks small molecules for RNA in deal with Ribometrix

...Ribometrix raised $7.8 million in additional funding from existing investors, the Dementia Discovery Fund and Illumina Ventures...
BioCentury | Sep 13, 2019
Tools & Techniques

Enzymes aim to beat chemistry by creating longer, speedier, cleaner DNA strands

...1H20, and has raised over $50 million in a 2017 series A round led by Illumina Ventures...
BioCentury | Jul 18, 2019
Emerging Company Profile

DNA Script: enzymatic DNA synthesis

...Combinatorial Chemistry LLC Number of employees: 40 Funds raised: $53 million Investors: Life Science Partners, Illumina Ventures...
BioCentury | Jul 16, 2019
Financial News

July 16 Financial Quick Takes: J&J growth drivers beat consensus; plus Notable and Cradle raise funds

...company Cradle Genomics (San Diego, Calif.) launched with $17.1 million in a series A round. Illumina Ventures...
Items per page:
1 - 10 of 32
BioCentury | Jan 15, 2021
Product Development

Delfi and Earli series A rounds show there’s room for new entrants in early cancer detection

...OrbiMed, the series A round had participation from existing investors including Menlo Ventures, Samsara Biocapital, Illumina Ventures...
...company raised a $5.5 million seed financing led by Menlo Ventures and including Samsara BioCapital, Illumina Ventures...
BioCentury | Oct 17, 2020
Finance

Menlo to continue healthcare push at intersection of tech, life sciences with $500M fund

...as CEO of digital health and next-generation protein analysis companies as well as an entrepreneur-in-residence at Illumina Ventures...
BioCentury | Jul 23, 2020
Product Development

Encoded to drive first gene therapy into clinic with GV-led $135M series D

...the vector. The financing drew participation from existing investors Matrix Capital Management, Arch Venture Partners, Illumina Ventures...
BioCentury | May 18, 2020
Finance

$65M round positions SQZ Biotech for potential IPO, 2021 catalysts

...investor Temasek, bringing its total of private capital raised to $167 million. Existing investors GV, Illumina Ventures...
BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...series A led by Boehringer Ingelheim Venture Fund (BIVF) and Panacea Venture, with participation from Illumina Ventures...
BioCentury | Mar 25, 2020
Finance

‘Diversified’ gut-brain axis company Kallyope heading to clinic with $112M series C

...the new round: The Column Group, Lux Capital, Polaris Partners, Euclidean Capital, Two Sigma Ventures, Illumina Ventures...
BioCentury | Sep 30, 2019
Company News

Vertex seeks small molecules for RNA in deal with Ribometrix

...Ribometrix raised $7.8 million in additional funding from existing investors, the Dementia Discovery Fund and Illumina Ventures...
BioCentury | Sep 13, 2019
Tools & Techniques

Enzymes aim to beat chemistry by creating longer, speedier, cleaner DNA strands

...1H20, and has raised over $50 million in a 2017 series A round led by Illumina Ventures...
BioCentury | Jul 18, 2019
Emerging Company Profile

DNA Script: enzymatic DNA synthesis

...Combinatorial Chemistry LLC Number of employees: 40 Funds raised: $53 million Investors: Life Science Partners, Illumina Ventures...
BioCentury | Jul 16, 2019
Financial News

July 16 Financial Quick Takes: J&J growth drivers beat consensus; plus Notable and Cradle raise funds

...company Cradle Genomics (San Diego, Calif.) launched with $17.1 million in a series A round. Illumina Ventures...
Items per page:
1 - 10 of 32